Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-agonists.

Ellen J Dutta1, James T C Li

  • 1Division of Allergic Diseases and Internal Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.

The Medical Clinics of North America
|November 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biphasic, refractory, and life-threatening anaphylactic reactions to iodinated contrast media: A 10-year retrospective analysis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Anaphylaxis to ultrasound-enhancing agent with transient elevation in serum tryptase.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2022
Same author

Long QT syndrome and life-threatening anaphylaxis: Is epinephrine safe?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2016
Same author

Appropriateness of epinephrine use in ED patients with anaphylaxis.

The American journal of emergency medicine·2015
Same author

Predictors of Repeat Epinephrine Administration for Emergency Department Patients with Anaphylaxis.

The journal of allergy and clinical immunology. In practice·2015
Same author

Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.

Allergy and asthma proceedings·2015
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Beta-agonists are essential for asthma management, offering quick symptom relief and long-term control. These safe and effective bronchodilators, including short-acting and long-acting forms, help manage nocturnal and exercise-induced asthma.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Beta-agonists are a cornerstone of asthma management.
  • They function as bronchodilators, crucial for symptom relief.

Purpose of the Study:

  • To outline the therapeutic roles of beta-agonists in asthma.
  • To highlight their efficacy in different asthma phenotypes and situations.

Main Methods:

  • Review of the established clinical applications of beta-agonists.
  • Analysis of short-acting and long-acting beta-agonist mechanisms and uses.

Main Results:

  • Short-acting beta-agonists provide rapid relief for asthma symptoms.
  • Long-acting beta-agonists are vital for sustained asthma control, particularly with inhaled corticosteroids and for nocturnal asthma.

Related Experiment Videos

  • Both forms are effective for exercise-induced asthma prophylaxis, with long-acting agents offering extended protection.

    • Conclusions:

    • Beta-agonists are safe and effective bronchodilators for various asthma management needs.
    • Appropriate use of short-acting and long-acting beta-agonists is key to optimizing asthma control and patient outcomes.